GetTopicDetailResponse(id=d5413258ab, topicName=BCL-2口服選擇性抑制劑ZN-d5, introduction=BCL-2口服選擇性抑制劑ZN-d5, content=null, image=null, comments=1, allHits=985, url=https://h5.medsci.cn/topic?id=3258, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103066, tagList=[TagDto(tagId=103066, tagName=BCL-2口服選擇性抑制劑ZN-d5)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1984858, encodeId=b11c1984858f4, content=<a href='/topic/show?id=d5413258ab' target=_blank style='color:#2F92EE;'>#BCL-2口服選擇性抑制劑ZN-d5#</a>, objectTitle=FDA批準BCL-2口服選擇性抑制劑ZN-d5的IND申請，用于治療血液系統(tǒng)惡性腫瘤, objectType=article, longId=193383, objectId=4d63193383b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d63193383b1, replyNumber=0, likeNumber=77, createdTime=2021-03-27, rootId=0, userName=12498761m56暫無昵稱, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d63193383b1, moduleTitle=FDA批準BCL-2口服選擇性抑制劑ZN-d5的IND申請，用于治療血液系統(tǒng)惡性腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4d63193383b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
